BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
32990384
Number of visits today
3328
Number of downloads
16170351
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Stikker BS, Stik G, van Ouwerkerk AF, Trap L, Spicuglia S, Hendriks RW, Stadhouders R. Severe COVID-19-associated variants linked to chemokine receptor gene control in monocytes and macrophages. Genome Biol 2022;23. [DOI: 10.1186/s13059-022-02669-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Jeyananthan P. Role of different types of RNA molecules in the severity prediction of SARS-CoV-2 patients. Pathol Res Pract 2023;242:154311. [PMID: 36657221 DOI: 10.1016/j.prp.2023.154311] [Reference Citation Analysis]
2 Tanaka T, Suzuki H, Asano T, Li G, Nanamiya R, Tateyama N, Isoda Y, Okada Y, Kobayashi H, Yoshikawa T, Kaneko MK, Kato Y. Epitope Mapping of an Anti-Mouse CCR2 Monoclonal Antibody (C(2)Mab-6) Using Enzyme-Linked Immunosorbent Assay. Monoclon Antib Immunodiagn Immunother 2022;41:339-42. [PMID: 36346278 DOI: 10.1089/mab.2022.0020] [Reference Citation Analysis]
3 Pius-sadowska E, Niedźwiedź A, Kulig P, Baumert B, Sobuś A, Rogińska D, Łuczkowska K, Ulańczyk Z, Wnęk S, Karolak I, Paczkowska E, Kotfis K, Kawa M, Stecewicz I, Zawodny P, Machaliński B. CXCL8, CCL2, and CMV Seropositivity as New Prognostic Factors for a Severe COVID-19 Course. IJMS 2022;23:11338. [DOI: 10.3390/ijms231911338] [Reference Citation Analysis]
4 Singh Y, Selting AS, Gabernet G, Ray U, Bajaj R, Ali M, Loitz M, Hammer V, Buena-atienza E, Ruschil C, Huebener-schmid J, Kowarik M, Salker MS, Casadei N, Nahnsen S, Kremsner P, Ossowski S, Altmann DM, Riess O, Deutsche COVID-19 OMICS Initiative (DeCOI). Comparative multi-OMICS single cell atlas of five COVID-19 (rAdVV and mRNA) vaccines describe unique and distinct mechanisms of action.. [DOI: 10.1101/2022.09.12.507666] [Reference Citation Analysis]
5 Gray PE, Bartlett AW, Tangye SG. Severe COVID-19 represents an undiagnosed primary immunodeficiency in a high proportion of infected individuals. Clin Transl Immunology 2022;11:e1365. [PMID: 35444807 DOI: 10.1002/cti2.1365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345